Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age

ASEM 文献综述

Official National Advisory Committee on Immunization document (2022) on “Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age”. Following consultation with HIV experts, NACI has updated the suggested list of conditions for children 5 to 11 years of age to be considered moderately to severely immunocompromised.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。